{ "cik": 1434647, "cik_padded": "0001434647", "entityName": "ZEVRA THERAPEUTICS, INC.", "fiscal_years": [ { "accn": "0001434647-26-000011", "filed": "2026-03-09", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 835000.0, "cash": 62406000.0, "eps_diluted": 1.35, "free_cash_flow": -2433000.0, "net_income": 83229000.0, "operating_cash_flow": -1598000.0, "operating_income": -62943000.0, "revenue": 106470000.0, "stockholders_equity": 154657000.0, "total_assets": 284731000.0, "total_liabilities": 130074000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8410482551711206, "net_margin": 0.7817131586362356, "operating_margin": -0.5911806142575373, "revenue_growth_yoy": 3.5091478909029306, "roa_avg2y": 0.3596308154984898, "roa_period_end": 0.29230747617927094, "roe_avg2y": 0.8566047251226051, "roe_period_end": 0.5381521689933207 } }, { "accn": "0001434647-26-000011", "filed": "2026-03-09", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 0.0, "cash": 33785000.0, "eps_diluted": -2.28, "free_cash_flow": -69665000.0, "net_income": -105511000.0, "operating_cash_flow": -69665000.0, "operating_income": -87003000.0, "revenue": 23612000.0, "stockholders_equity": 39666000.0, "total_assets": 178127000.0, "total_liabilities": 138461000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.4906721121363384, "revenue_growth_yoy": -0.14016241214813735, "roa_avg2y": -0.6021389397752629, "roa_period_end": -0.592335805352361, "roe_avg2y": -2.078420171377918, "roe_period_end": -2.6599858821156657 } }, { "accn": "0001437749-25-007320", "filed": "2026-03-09", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 3447000.0, "capex": 296000.0, "cash": 43049000.0, "free_cash_flow": -33831000.0, "net_income": -46049000.0, "operating_cash_flow": -33535000.0, "operating_income": -49604000.0, "revenue": 27461000.0, "stockholders_equity": 61864000.0, "total_assets": 172327000.0, "total_liabilities": 110463000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.7855780421569896, "revenue_growth_yoy": 1.7025883279204803, "roa_avg2y": -0.3201549013268814, "roa_period_end": -0.26721871790259216, "roe_avg2y": -0.6723266950884775, "roe_period_end": -0.7443585930428036 } }, { "accn": "0001437749-25-007320", "filed": "2025-03-12", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 4723000.0, "capex": 93000.0, "cash": 65466000.0, "free_cash_flow": -18810000.0, "net_income": -26772000.0, "operating_cash_flow": -18717000.0, "operating_income": -42565000.0, "revenue": 10161000.0, "stockholders_equity": 75120000.0, "total_assets": 115340000.0, "total_liabilities": 40220000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5354100106496272, "revenue_growth_yoy": -0.6453403141361257, "roa_avg2y": -0.21565887039282103, "roa_period_end": -0.23211375065025144, "roe_avg2y": -0.30288494173549046, "roe_period_end": -0.35638977635782754 } }, { "accn": "0001437749-24-010430", "filed": "2024-04-01", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 2814000.0, "capex": 102000.0, "cash": 112346000.0, "eps_diluted": -2.11, "free_cash_flow": 10337000.0, "net_income": -8555000.0, "operating_cash_flow": 10439000.0, "operating_income": 7729000.0, "revenue": 28650000.0, "stockholders_equity": 101660000.0, "total_assets": 132941000.0, "total_liabilities": 5823000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05727916584694078, "net_margin": -0.2986038394415358, "operating_margin": 0.26977312390924957, "revenue_growth_yoy": 1.1560806742925949, "roa_avg2y": -0.11869580298300382, "roa_period_end": -0.06435185533432124, "roe_avg2y": -0.4854176123467998, "roe_period_end": -0.08415305921699784 } }, { "accn": "0001437749-23-005703", "filed": "2023-03-07", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 33000.0, "cash": 4213000.0, "eps_diluted": -3.21, "free_cash_flow": -1972000.0, "net_income": -12760000.0, "operating_cash_flow": -1939000.0, "operating_income": -5609000.0, "revenue": 13288000.0, "stockholders_equity": -66412000.0, "total_assets": 11209000.0, "total_liabilities": 77621000.0 }, "period_end": "2020-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.9602649006622517, "operating_margin": -0.4221101745936183, "revenue_growth_yoy": 0.03497157099462575, "roa_avg2y": -1.175170381285688, "roa_period_end": -1.138370951913641, "roe_avg2y": 0.18116250674390208 } }, { "accn": "0001437749-22-007725", "filed": "2022-03-31", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 26000.0, "cash": 3217000.0, "free_cash_flow": -23763000.0, "net_income": -24522000.0, "operating_cash_flow": -23737000.0, "operating_income": -20337000.0, "revenue": 12839000.0, "stockholders_equity": -74456000.0, "total_assets": 10507000.0, "total_liabilities": 84963000.0 }, "period_end": "2019-12-31", "ratio_units": { "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -1.3165114218989076, "roe_avg2y": 0.34777552438626597 } }, { "accn": "0001437749-21-005785", "filed": "2021-03-12", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 21000.0, "cash": 18409000.0, "free_cash_flow": -54224000.0, "net_income": -56466000.0, "operating_cash_flow": -54203000.0, "operating_income": -55903000.0, "stockholders_equity": -66566000.0, "total_assets": 26746000.0, "total_liabilities": 93312000.0 }, "period_end": "2018-12-31", "ratio_units": { "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -1.42587308401303, "roe_avg2y": 0.9101400686642704 } }, { "accn": "0001437749-20-003965", "filed": "2020-02-28", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 181000.0, "cash": 10871000.0, "free_cash_flow": -33281000.0, "net_income": -43386000.0, "operating_cash_flow": -33100000.0, "operating_income": -33366000.0, "stockholders_equity": -57516000.0, "total_assets": 52456000.0, "total_liabilities": 109972000.0 }, "period_end": "2017-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.6317904807671305, "roa_period_end": -0.8270931828580143, "roe_avg2y": 1.1385608565580223 } }, { "accn": "0001437749-19-003789", "filed": "2019-03-01", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 643000.0, "cash": 16762000.0, "free_cash_flow": -30415000.0, "net_income": -16516000.0, "operating_cash_flow": -29772000.0, "operating_income": -37482000.0, "stockholders_equity": -18696000.0, "total_assets": 84887000.0, "total_liabilities": 103583000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio" }, "ratios": { "roa_period_end": -0.19456453873973636 } } ], "latest_filing": { "accn": "0001434647-26-000011", "filed": "2026-03-09", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001434647.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001434647.json" }, "ticker": "ZVRA" }